References
- McCluskeyL, CasarettD, SiderowfA. ALS. 2004;5:131–5.
- NICE (NG42). 2016
- AounSM, BreenLJ, HowtingD, et al. ALS. 2016;17:168–178
- BaileWF, BuckmanR, LenziR, et al. Oncologist. 2000;5:302–11.
References
- AtaliaA, De Carvalho M, Evangelista T, et al. Lateral Scler. 2007;8(2):101–5.
- Musiek, Erik S. Front Pharmacol. 2018;6:29.
References
- GagnonMP1, OrruñoE, AsuaJ, et al. Telemed J E Health. 2012;18(1):54–9.
- PaganoniS, SimmonsZ. Muscle Nerve. 2019;59(1):3–5.
References
- CedarbaumJM, StamblerN, MaltaE, et al. J Neurol Sci. 1999;169:13–21.
- ShefnerJM. Neurotherapeutics. 2017;14(1):154–160.
- RadovanovićS, MilićevM, PerićS, et al. Amyotroph Lateral Sc Fr. 2014;15(7–8):488–93.
- AndersenPM, BorasioGD, DenglerR, et al. Amyotroph Lateral Sc. 2007;8:195–213.
References
- LuiAJ, BylNN. J Neurol Phys Ther. 2009;33(2):68–87.
- VeldinkJH, KalmijnS, GroeneveldGJ, et al. Neurology. 2005;64(2):241–245.
Reference
- KarthausM, FalkensteinM. Geriatrics. 2016;1(2):12.
Reference
- Ishijima, Adachi, Kawaguchi, et al. ALS. 2017; The 28th International Symposium on ALS/MND.
References
- AounSM, Bentley B, Funk L, et al. Palliative Med. 2013; 27(5):437–46.
- ChuHS, TakYR. KimSH. J Korean Acad Nurs. 2018:48(4):454–64.
References
- RosenbekJC, RobbinsJA, RoeckerEB, et al. Dysphagia. 1996;11(2):93–98.
- ScottA, PerryA, BenchJ. Dysphagia. 1998;13:223–227.
References
- Connors, K, MahonyL & MorganP. Neurorehabilitation. 2019;44:303–313.
- https://www.nice.org.uk/guidance/ng42/chapter/Recommendations#managing-symptoms
References
- RestivoD, CasbonaA, NicotraA, et al. ALS. 2013; 80(7):616–620.
- CockC, OmariT. Curr Gastroenterol Rep. 2017;19(3):11.
- RosenbekJ, RobbinsJ, RoeckerE, et al. Dysphagia. 1996; 11(2):93–98.
- PearsonW, MolfenterS, SmithZ, et al. Dysphagia. 2013; 28(2):167–177.
References
- TaborL, PlowmanK. Med Radiol. 2019;0:165–174.
- MND Australia Research Priorities Survey Community Consultation Report, 2018
- WoolleyS, YorkM, MooreH, et al. ALS. 2010; 11(3): 303–311.
- OnestiE, SchettinoI, GoriM, et al. Front Neurol. 2017;8:94.
- ArkseyH, O’MalleyL, Int J Soc Res Methodol. 2005;8(1):19–32.
Reference
- CostelloJ. (2012) Preserving legacy: A guide to Message Banking a patient’s voice. Continuing Professional Development Course, Trinity College Dublin, Ireland, 28th September.
Reference
- NaritaY, KatoM, NishiiN, et al. ISASE. 2018; ISASE2018:A1–4.
References
- MoorcroftA, ScarinciN, MeyerC. Disabil Rehabil Assist Technol. 2018;1–22.
- NaritaY, KatoM, NishiiN, et al. ISASE. 2018;ISASE2018:A1–4.
- ArcoraciV, SquadritoF, AltavillaD, et al. Pharmacol Res Perspect. 2019;7(1):e00449.
References
- MoroC, StrombergaA, RaikosA, et al. Anat Sci Ed. 10(6), 549–559.
- Holton-BurkeJ, VotaS, Oyoung-OliverD. Adding Virtual Reality into the Neurology Curriculum. Published abstract. American Academy of Neurology Annual Meeting. May 2019. Philadelphia.
References
- Le BlancK. Cytotherapy. 2003;5(6):485–9.
- FornaiF, LongoneP, CafaroL, et al. P Natl A Sci. 2008;105(6):2052–7.
Reference
- QureshiI, Wirtz V, Coric V, et al. A phase 1 study to evaluate bioequivalence between BHV-0223 40 mg zydis sublingual formulation and riluzole 50mg oral tablet in healthy volunteers. 2018. Retrieved from https://www.biohavenpharma.com/sites/default/files/documents/bvh-0223-bioequivalence-aanem-2018.pdf
Reference
- QureshiI, Wirtz V, Coric V, et al. (2018). A phase 1 study to evaluate bioequivalence between BHV-0223 40 mg zydis sublingual formulation and riluzole 50mg oral tablet in healthy volunteers. https://www.biohavenpharma.com/sites/default/files/documents/bvh-0223-bioequivalence-aanem-2018.pdf
References
- RADICAVA® (edaravone injection) [package insert]. Jersey City, NJ: Mitsubishi Tanabe Pharma America, Inc; August 2018.
- Writing Group; Edaravone (MCI-186) ALS 19 Study Group. Lancet Neurol. 2017;16:505–512.
- Soleo Health. https://www.soleohealth.com. Accessed on May 20, 2019.
References
- WestenengH-J, DebrayTPA, VisserAE, et al. Lancet Neurol. 2018;17(4): 423–433.
- MitsumotoH. Lancet Neurol. 2018;17(5):386–388.
- ClaytonJM, HancockK, ParkerS, et al. Psychooncology. 2008;17:641–659.
Reference
- HogdenA, AounS, SilbertP. Neurol. 2018;6(1):68–76.